1. Home
  2. SYNX vs SYBX Comparison

SYNX vs SYBX Comparison

Compare SYNX & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYNX
  • SYBX
  • Stock Information
  • Founded
  • SYNX 2005
  • SYBX N/A
  • Country
  • SYNX Israel
  • SYBX United States
  • Employees
  • SYNX N/A
  • SYBX N/A
  • Industry
  • SYNX
  • SYBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SYNX
  • SYBX Health Care
  • Exchange
  • SYNX Nasdaq
  • SYBX Nasdaq
  • Market Cap
  • SYNX 15.6M
  • SYBX 17.0M
  • IPO Year
  • SYNX 2024
  • SYBX N/A
  • Fundamental
  • Price
  • SYNX $3.07
  • SYBX $1.37
  • Analyst Decision
  • SYNX
  • SYBX Hold
  • Analyst Count
  • SYNX 0
  • SYBX 3
  • Target Price
  • SYNX N/A
  • SYBX $1.00
  • AVG Volume (30 Days)
  • SYNX 36.1K
  • SYBX 71.5K
  • Earning Date
  • SYNX 12-31-2024
  • SYBX 11-12-2024
  • Dividend Yield
  • SYNX N/A
  • SYBX N/A
  • EPS Growth
  • SYNX N/A
  • SYBX N/A
  • EPS
  • SYNX N/A
  • SYBX N/A
  • Revenue
  • SYNX $9,893,000.00
  • SYBX $2,777,000.00
  • Revenue This Year
  • SYNX $52.34
  • SYBX N/A
  • Revenue Next Year
  • SYNX N/A
  • SYBX N/A
  • P/E Ratio
  • SYNX N/A
  • SYBX N/A
  • Revenue Growth
  • SYNX 18.05
  • SYBX 292.23
  • 52 Week Low
  • SYNX $2.10
  • SYBX $1.22
  • 52 Week High
  • SYNX $4.25
  • SYBX $5.12
  • Technical
  • Relative Strength Index (RSI)
  • SYNX 52.51
  • SYBX 41.68
  • Support Level
  • SYNX $2.74
  • SYBX $1.44
  • Resistance Level
  • SYNX $4.25
  • SYBX $1.88
  • Average True Range (ATR)
  • SYNX 0.44
  • SYBX 0.09
  • MACD
  • SYNX 0.06
  • SYBX -0.00
  • Stochastic Oscillator
  • SYNX 32.18
  • SYBX 1.92

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Share on Social Networks: